Remove 2014 Remove Invention Remove Licensing
article thumbnail

Book Review: Intellectual Property as a Complex Adaptive System

The IPKat

In Chapter 4, Beatriz Conde Gallego debates whether owners of standard-essential patents (SEPs) must grant licences in “license to all” or “access to all” approaches. Chapter 6, authored by Ryan Abbott, ponders whether current patentability criteria may fit AI-generated inventions.

article thumbnail

Zolgensma and the Inadequacies of the Compulsory Licensing Regime

SpicyIP

Zolgensma and the Inadequacies of the Compulsory Licensing Regime. Compulsory Licensing: Chinks in the Armor. The TRIPS Agreement has incorporated certain fail-safes in the form of Compulsory Licenses for when patents are seen to be acting contrary to public need. The invention not being reasonably affordable.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Revocation of Patents

IP and Legal Filings

These grounds are as follows: The invention was already claimed in an earlier valid patent in India. The subject of the patent claim does not qualify as an invention within the meaning of this Act. The subject of the patent claim does not qualify as an invention within the meaning of this Act. The invention is not useful.

Patent 96
article thumbnail

Generative AI and Patent Considerations – Part Two

Intellectual Property Law Blog

Patent Office guidelines along with real-life prosecution experience fortunately provide a roadmap to avoid that fate for generative AI inventions. As set forth in Example 39, a discussion of technological challenges overcome by the inventive generative model should be set forth in detail in the patent application. 208 (2014)?

Patent 130
article thumbnail

Patent Application for Gilead’s Lenacapavir Opposed: Saving Generics of HIV Drugs?

SpicyIP

It is a prescription drug for treating HIV in adults, available in tablet and injectable forms, and is used in combination with other HIV medicines, currently licensed for treatment, not prevention, due to its high prices. The looming threat is the pending patent applications by Gilead in India.

article thumbnail

Over the Last Decade India has Spent Rs. 1,00,000 crores on Scientific Research with No Transparency: Time to Resuscitate the PUPFIP?

SpicyIP

Subsequent to the tabling of the report, the UPA government never really made a push for the legislation and it was withdrawn from the Rajya Sabha by the Modi government in December 2014. This was a serious issue in the United States for some COVID vaccines that were funded through grants from the American government.

article thumbnail

Adding matter by cherry-picking from separate embodiments: Philip Morris v BAT ([2023] EWHC 2616 (Pat))

The IPKat

During proceedings, BAT submitted an amendment to the claims in an attempt to overcome invalidity for inventive step. Limited [2020] EWCA Civ 1292, AP Racing Ltd v Alcon Components Ltd [2014] EWCA Civ 40 ). PM sought revocation of the patent, and BAT counterclaimed infringement of the patent by PM's heat-not-burn IQOS ILUMA device.

Invention 113